|
Profile: Government warns naproxen may increase risk of heart attacks and strokes
Morning Edition (NPR); 12/21/2004; STEVE INSKEEP, RENEE MONTAGNE; 787 words
; ... NPR) 12-21-2004 Profile: Government warns naproxen may increase risk of heart attacks and strokes ... host: This is MORNING EDITION from NPR News. I'm Steve Inskeep. RENEE MONTAGNE, host ... of others who use the common painkiller naproxen. It's a generic drug sold under the brand ... others. A federally ...
Read more
|
|
Side effects halt naproxen study
Deseret News (Salt Lake City); 12/21/2004; Paul Recer Associated Press; 533 words
; ... A study testing whether Celebrex or naproxen would reduce the risk of Alzheimer's ... stroke among participants who were taking naproxen, an over-the-counter pain reliever on ... when it was noticed that patients taking naproxen, sold under the brand name Aleve, had ...
Read more
|
|
Case report: Naproxen-associated sudden sensorineural hearing loss
Military Medicine; 11/1/1998; McKinnon, Brian J; Lassen, Lorenz F; 787 words
; ... MC USN* CAPT Lorenz F. Lassen, MC USN* Naproxen is a commonly used nonsteroidal anti ... hearing loss after a brief course of naproxen and reviews the literature on NSAID-related ... sensorineural hearing loss. Introduction Naproxen is a commonly used nonsteroidal anti ...
Read more
|
|
Where the Naproxen Story Went Wrong; When NIH Halted a Major Study, Citing Risks From a Common Painkiller, the Media Played the News Big. That Was Just Part of the Problem
The Washington Post; 2/1/2005; Steven Woloshin Lisa M. Schwartz and H. Gilbert Welch; 787 words
; Medical research often becomes news. But sometimes the news is made to appear ... about the safety of a widely used drug like naproxen, also known as Aleve, is big health news ... ADAPT) because of safety concerns about naproxen received intense media coverage. In the ... headlines included: "Heart ...
Read more
|
|
Naproxen also comes under fire.(Supplier News)(Brief Article)
Chain Drug Review; 1/3/2005; 188 words
; WASHINGTON -- The bad news about the potential risk of anti-inflammatory medications ... when the Food and Drug Administration announced that naproxen might increase people risk of having a heart attack or stroke. Naproxen, one version of which is sold by prescription, is also ... several generic versions ...
Read more
|
|
New advice: Naproxen is safe for pain
Chicago Sun-Times; 9/13/2006; 182 words
; ... of dozens of studies, indicate most patients should try naproxen, an older anti- inflammatory drug commonly sold as Aleve ... or stroke risk -- a major worry for older people -- and naproxen is inexpensive because generic versions have been around ... newer acid reflux drugs. "I do think we should start with ...
Read more
|
|
Health Buzz: Celebrex, Naproxen, and Other Health News.
U.S. News & World Report; 5/13/2008; Payne, January W.; 787 words
; ... anti-inflammatory medicines Celebrex and naproxen does not appear to slow mental ... healthday/2008/05/12/celebrex-naproxen-wont-prevent-mental-decline ... participants were assigned to take naproxen, Celebrex, or a placebo twice ... health-buzz-ibuprofen-and-alzheimers-and-other-health-news.html) of ...
Read more
|
|
Characterization of the transient intermediates generated from the photoexcitation of nabumetone: A comparison with naproxen
Photochemistry and Photobiology; 11/1/1998; Martinez, Lydia J; Scaiano, J C; 787 words
; ... nabumetone are compared with those of naproxen, a structurally related acidic nonsteroidal ... favorably with other NSAIDs like diclofenac, naproxen and piroxicam (1). The incidence of gastrointestinal ... being its metabolite 6MNAA, which is a naproxen analog (5). As with other anti-inflammatory ...
Read more
|
|
Naproxen Versus Rofecoxib.
OB GYN News; 9/1/2000; Kubetin, Sally Koch; 176 words
; ... significant upper GI events as patients taking standard doses of naproxen. The results of the large prospective study, funded by Merck ... dose of rofecoxib than in patients taking standard doses of naproxen. Upper GI events considered to be complicated, a category that ...
Read more
|
|
Naproxen debut.
Chain Drug Review; 8/31/1998; 24 words
; Teva Pharmaceuticals USA has debuted naproxen delayed-release tablets in 375 and 500 mg. They are rated bioequivalent to Hoffmann-La Roche Inc.'s EC-Naprosyn.
Read more
|